See every side of every news story
Published loading...Updated

Dexcom aims to bring CGM to more people with type 2 diabetes

Summary by Drug Delivery Business
A man swimming with the Stelo sensor. [Image courtesy of Dexcom]Of the hundreds of millions of people living with diabetes, the vast majority live with type 2. Dexcom (Nasdaq:DXCM) wants to make sure they have the tools to manage that. The International Diabetes Federation says that more than 90% of people with diabetes have type 2 diabetes. Yet, that population remains significantly under-penetrated by the wide range of diabetes technologies av…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Drug Delivery Business broke the news in on Friday, March 21, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.